NCT04106219 2026-04-21
A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Eli Lilly and Company
Phase 1 Active not recruiting
Clinical Trials
13 trialsNCT07460037 2026-03-10
Chinese-Specific Speech Imagery Coding Using High-Density ECoG
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Recruiting
NCT05104983 2026-01-22
TSC-STEPS
Children's Hospital Medical Center, Cincinnati
Phase 2 Recruiting
NCT04266041 2025-12-12
High-density EEG in Neurological Disorders
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT05626634 2025-12-03
Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Phase 2 Completed
NCT04485104 2025-10-31
Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
Jazz Pharmaceuticals
Phase 3 Terminated
NCT05014841 2025-09-16
The Neural Coding of Speech Across Human Languages
University of California, San Francisco
Phase NA Enrolling by invitation
NCT07165262 2025-09-10
ECOG-Anaes
Children's Cancer Hospital Egypt 57357
Phase 3 Active not recruiting
NCT06391294 2025-09-09
Neuronal and Network Mechanisms of Electrocortical Stimulation
Northwestern University
Phase NA Enrolling by invitation
NCT05989893 2025-08-28
Mapping of Human Cognition
The University of Texas Health Science Center, Houston
Phase NA Recruiting
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT03731455 2025-07-17
WIN
Wise S.r.l.
Phase NA Completed
NCT05435859 2025-06-08
Functional Organization of the Superior Temporal Gyrus for Speech Perception
University of California, San Francisco
Phase NA Enrolling by invitation